GeoVax's GEO-CM04S1 Vaccine Shows Superior Protection in Immunocompromised Populations
May 20, 2025 — GeoVax Labs, Inc. announces the effectiveness of GEO-CM04S1 vaccine in immunocompromised populations, aligning with new HHS guidelines. The vaccine offers superior protection and durability, crucial for vulnerable individuals with weakened immune systems.